+86-28-82633987sales@biopurify.com
Batch Structure Search
Home > Product Category > Botanical Source > Aconitum carmichaelii Debx.

Benzoylmesaconine

CAS No.:63238-67-5

Benzoylmesaconine
Catalogue No.: BP0246
Formula: C31H43NO10
Mol Weight: 589.682
Botanical Source: Aconitum carmichaelii Debx.
Contacts
+86-28-82633860  +86-18080483897
 
Email: sales@biopurify.com biopurify@gmail.com
We have been the main supplier of phytochemicals worldwide for more than 10 years, please feel free to contacrt us!

Product name: Benzoylmesaconine
Synonym name:
Catalogue No.: BP0246
Cas No.: 63238-67-5
Formula: C31H43NO10
Mol Weight: 589.682
Botanical Source:
Physical Description: Powder
Type of Compound: Alkaloids

Purity: 95%~99%
Analysis Method: HPLC-DAD or/and HPLC-ELSD
Identification Method: Mass, NMR
Packing: Brown vial or HDPE plastic bottle

Storage: Store in a well closed container, protected from air and light. Put into refrigerate or freeze for long term storage.
Whenever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20℃. Generally, these will be useable for up to two weeks.

The product could be supplied from milligrams to grams, up to kilograms
Inquire for bulk scale.

Descriptions:
Benzoylmesaconine (BEN, an aconitine derivative extracted from heated-Aconiti tuber) induces the generation of CD4+ T cells antagonistic to type 2 T cells (BEN-CD4+ T cells), the combination therapy of IL-12 (an inducer of type 1 T cell responses) and BEN (an inhibitor of type 2 T cell responses) may protect TI-mice from severe HSV-1 infection.
Benzoylmesaconine has antinociceptive effects.[1]
Benzoylmesaconine has inhibition effects on opportunistic herpesvirus infections in mice with acquired immunodeficiency syndrome.[2]

References:
[1] Kobayashi M, Takahashi H, Herndon D N, et al. Burns, 2003, 29(1):37-42.
[2] Suzuki Y, Oyama T, Ishige A, et al. Planta Med, 1994, 60(5):391-4.
[3] Ball Ma, Kobayashi, Polland R B, et al. J Immunother, 1995, 17(2):127.
[4] Nie J, Zhang L, Tian S. China Pharmacist, 2003, 6(01):38-9.